June 26, 2026

• 12:00 PM · BioWorld
  12:00 PMEMA to pull Amgen’s Tavneos over ‘incorrect and misleading’ data — BioWorld
• 12:00 PM · BioWorld
  12:00 PMHigh-profile Nature retraction tests confidence in China-led studies — BioWorld
• 11:49 AM · BioPharma Dive
  11:49 AMAt BIO, tension over China biotech deal regulation looms — BioPharma Dive
• 9:46 AM · BioPharma Dive
  9:46 AMAlkermes’ incoming CEO has a plan to outplay Lilly and Takeda — BioPharma Dive
• 9:00 AM · BioWorld
  9:00 AMOblenio’s $62M series B for trispecific antibody in autoimmune diseases — BioWorld
• 9:00 AM · BioWorld
  9:00 AMElixirgen and Nippon Shinyaku sign EXG-7001 option agreement — BioWorld
• 8:29 AM · STAT News
  8:29 AMSTAT+: European antitrust regulators probe Sanofi for allegedly disparaging a rival flu vaccine — STAT News
• 8:20 AM · FT — Pharmaceuticals
  8:20 AMBrussels launches antitrust probe into French drugmaker Sanofi — FT — Pharmaceuticals
• 6:23 AM · Pharmaceutical Technology
  6:23 AMImmunai and Boehringer partner to identify T-cell targets — Pharmaceutical Technology
• 5:27 AM · Pharmaceutical Technology
  5:27 AMLilly-backed Absci banks $100m to progress endometriosis, hair loss therapy — Pharmaceutical Technology
• 5:17 AM · Pharmaceutical Technology
  5:17 AMIonis grants Recordati rights to zilganersen for Alexander disease — Pharmaceutical Technology
• 5:00 AM · Drug Discovery World
  5:00 AMThalia acquires Sanmirna and AML RNA therapy — Drug Discovery World
• 4:00 AM · Drug Discovery World
  4:00 AMNICE recommends immunotherapy to treat cervical cancer — Drug Discovery World